Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

Min-Hee RyuKyung Hee LeeLin ShenKun-Huei YehChanghoon YooYoung Seon HongYoung Iee ParkSung Hyun YangDong Bok ShinDae Young ZangWon Ki KangIk-Joo ChungYeul Hong KimBaek-Yeol RyooByung-Ho NamYoung Soo ParkYoon-Koo Kang

Published in: Cancer medicine (2022)

The addition of sorafenib to XP chemotherapy was safe but not more effective than XP alone for first-line treatment of metastatic gastric cancer.

Keyphrases

phase ii study
open label
locally advanced
placebo controlled
squamous cell carcinoma
phase iii
double blind
rectal cancer
phase ii
clinical trial
small cell lung cancer
radiation therapy
study protocol
randomized controlled trial